Safetica Technologies Offers Free Data Security Audit and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Safetica Technologies Offers Free Data Security Audit and Data Loss Prevention Guide for Healthcare Professionals

NEWTON, N.C., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Whether intentional or not, more than 200 data breaches involving individual records for at least 500 patients each—a total of approximately 100,000 records—took place last year in the U.S., with potentially disastrous consequences for the firms involved. Studies also suggest that one in three patients will fall victim to data loss this year. That kind of careless data security, especially in light of stricter HIPAA compliance requirements for small to midsize healthcare businesses, could leave many businesses facing lawsuits, million-dollar fines or even jail time. The answer is internal data loss prevention (DLP) from companies such as Safetica Technologies , a leading provider of DLP software.

To help healthcare professionals work naturally and productively while protecting personal and financial information, Safetica is now offering a free security audit and Quick Guide for small to midsized businesses like pharmaceutical companies, urgent care centers, doctor and dental offices, and independent labs. DLP software employs encryption to safeguard records before they can be shared inappropriately or accidentally, rendering files useless to outsiders should they escape.

“The average cost to handle a data breach is $407 per compromised health care record, which could be catastrophic to a small business,” said Luke Walling, general manager of Safetica North America. “At Safetica, we're making sure all companies have the technology and expert support available to the giants of the industry so they can protect their business before a mistake or data breach happens.”

Starting today, any healthcare-related company can sign up for a free, customized data security audit to identify and assess potential data leaks and unsafe security practices within their organization. In addition, an online Quick Guide to Data Security for Healthcare Professionals is available at no cost, as well as an informative infographic . 

Safetica offers four unique benefits to healthcare companies, including:

  • Safetica spots risky behaviors among employees before they decide to leave a company or do harmful things, such as stealing sensitive data or selling medical records to criminals for profit. Safetica also prevents “good” employees from making inadvertent mistakes that can accidentally lead to data breaches. The software brings together web and application usage statistics to pinpoint high risk behaviors, saving your medical office from the potentially disastrous consequences of data theft or data leaks before they occur.
  • Safetica is designed to be highly intuitive for companies that do not have a large IT staff or highly developed data protection and security expertise. This makes it easier for businesses to comply with regulations such as HIPAA, SOX, and PCI security standards.
  • Safetica protects files based on how they are used. This contextual approach to DLP makes it easy to configure, install, and manage data in ways that don’t reduce productivity but immediately protect sensitive data.
  • Free support to get up and running: Safetica helps customers get started by providing free risk assessments and data audits to help identify how people are using data and where businesses are most vulnerable. They also provide personalized, ongoing technical and consultative support.

About Safetica

Since 2009, Safetica has been building data loss prevention (DLP) software to protect data in not just the enterprise, but also the world’s small and medium sized businesses. Safetica’s software is unique because it is easy to use, protects data against theft and mistakes while letting users work naturally, helps all businesses large and small comply with regulations, and is supported at no cost with the service levels businesses demand and deserve. Learn more at www.safeticausa.com .

Media Contacts: David Templeton pr@safeticausa.com (203) 530-0458  Carleen LeVasseur pr@safeticausa.com (408) 799-7728

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading